[go: up one dir, main page]

IL149004A0 - Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents - Google Patents

Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents

Info

Publication number
IL149004A0
IL149004A0 IL14900400A IL14900400A IL149004A0 IL 149004 A0 IL149004 A0 IL 149004A0 IL 14900400 A IL14900400 A IL 14900400A IL 14900400 A IL14900400 A IL 14900400A IL 149004 A0 IL149004 A0 IL 149004A0
Authority
IL
Israel
Prior art keywords
targeted
iron
biologically active
active agents
porous materials
Prior art date
Application number
IL14900400A
Other languages
English (en)
Original Assignee
Ferx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferx Inc filed Critical Ferx Inc
Publication of IL149004A0 publication Critical patent/IL149004A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Paints Or Removers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL14900400A 1999-10-18 2000-10-13 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents IL149004A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16029399P 1999-10-18 1999-10-18
PCT/US2000/028615 WO2001028587A2 (en) 1999-10-18 2000-10-13 Magnetic targeted carrier

Publications (1)

Publication Number Publication Date
IL149004A0 true IL149004A0 (en) 2002-11-10

Family

ID=22576298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14900400A IL149004A0 (en) 1999-10-18 2000-10-13 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents

Country Status (15)

Country Link
EP (1) EP1221974A2 (xx)
JP (3) JP2003512336A (xx)
KR (1) KR20020064299A (xx)
CN (1) CN1287859C (xx)
AU (1) AU772755B2 (xx)
BR (1) BR0014877A (xx)
CA (1) CA2387925A1 (xx)
CZ (1) CZ293919B6 (xx)
DE (1) DE1221974T1 (xx)
ES (1) ES2182731T1 (xx)
HK (1) HK1045110A1 (xx)
IL (1) IL149004A0 (xx)
MX (1) MXPA02003891A (xx)
NZ (1) NZ518311A (xx)
WO (1) WO2001028587A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
CN1879065A (zh) * 2003-09-12 2006-12-13 弗尔克斯破产财产公司 用于生物活性剂的定位传递的包含磁性成分和生物相容性聚合物的可磁靶向颗粒
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
US20080138437A1 (en) * 2004-02-09 2008-06-12 Shuji Sakuma Antitumor Agent
GB0403856D0 (en) * 2004-02-20 2004-03-24 Algeta As Composition
BRPI0507824A (pt) * 2004-02-20 2007-07-10 Algeta As hidroxiapatita, processo para a preparação de um particulado de hidroxiapatita marcada com radionuclìdeo, composição farmacêutica, uso de hidroxiapatita e de um radionuclìdeo emissor de alfa ou um radionuclìdeo emissor de beta, dispositivo, e, método de tratamento radioquìmico de um ser humano ou de um indivìduo animal não humano necessitando do mesmo
JP2006199810A (ja) * 2005-01-20 2006-08-03 Yokohama National Univ 複合粒子およびその製造方法
US8293274B2 (en) 2005-04-06 2012-10-23 Kabushiki Kaisha Sangi Intestinal absorptive anti-tumor agent
CN105476951A (zh) 2009-05-04 2016-04-13 普西维达公司 多孔硅药物洗脱颗粒
CA2816576C (en) * 2010-11-01 2020-06-02 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
EP2891716B1 (en) * 2012-08-28 2018-03-28 Biocube System Inc. Porous solid phase for rapidly isolating biological molecules for nucleic acid amplification reaction from biological sample, and use thereof
RU2705986C2 (ru) 2013-03-15 2019-11-13 Айпоинт Фармасьютикалз Юэс, Инк. Биоразлагаемые композиции на основе кремния для доставки терапевтических агентов
JP6443907B2 (ja) * 2014-02-17 2018-12-26 浩文 山本 造影剤の腫瘍への集積を促進するための集積促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243652A (en) * 1978-07-14 1981-01-06 The Procter & Gamble Company Gastrointestinal scanning agent
DE68920778T2 (de) * 1988-05-24 1995-05-18 Anagen Uk Ltd Magnetisch anziehbare Teilchen und Herstellungsverfahren.
US5928958A (en) * 1994-07-27 1999-07-27 Pilgrimm; Herbert Superparamagnetic particles, process for their manufacture and usage
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
JP3735990B2 (ja) * 1997-01-28 2006-01-18 東ソー株式会社 磁性シリカゲルの製造方法

Also Published As

Publication number Publication date
CZ20021357A3 (cs) 2002-11-13
BR0014877A (pt) 2002-06-11
JP2003321348A (ja) 2003-11-11
AU1090501A (en) 2001-04-30
CN1420787A (zh) 2003-05-28
EP1221974A2 (en) 2002-07-17
WO2001028587A2 (en) 2001-04-26
CA2387925A1 (en) 2001-04-26
JP2005200426A (ja) 2005-07-28
CN1287859C (zh) 2006-12-06
JP2003512336A (ja) 2003-04-02
ES2182731T1 (es) 2003-03-16
AU772755B2 (en) 2004-05-06
WO2001028587A3 (en) 2002-01-03
DE1221974T1 (de) 2003-02-06
HK1045110A1 (zh) 2002-11-15
NZ518311A (en) 2003-10-31
MXPA02003891A (es) 2002-12-09
KR20020064299A (ko) 2002-08-07
CZ293919B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
IL142807A0 (en) Controlled delivery of active agents
EP1183068A4 (en) ENHANCED ACTIVE AGENT DELIVERY METHOD BY ELECTROPORATION
IL155204A0 (en) Compositions and methods for the transport of biologically active agents across cellular barriers
GB2373477B (en) Nonwoven fabrics providing controlled active agent delivery
IL143962A0 (en) Polymeric delivery agents and delivery agent compounds
IL143857A0 (en) Transdermal delivery of fine powders
IL149004A0 (en) Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents
HUP0103188A2 (hu) Vegyületek és készítmények hatóanyagok célbajuttatására
GB0005839D0 (en) Storage and delivery of micro-organisms
AU8166098A (en) Removal of biologically active agents
IL145842A0 (en) Preparation of biologically active molecules
PL344077A1 (en) Incorporation of active substances in carrier matrixes
GB9930865D0 (en) Specially oriented material and magnetization of permanent magnets
IL146795A0 (en) Biologically active materials
IL148252A0 (en) Biodegradable solutions of biologically active compounds
AU6269901A (en) Biologically active agents and drugs
IL132137A0 (en) Biologically active substance on the basis of tetracyclic nitrogen heterocycles of pyrimidine row
AU2001262699A1 (en) Biologically active agents and drugs
GB9814851D0 (en) Biologically and therapeautically active agents
GB9915380D0 (en) Biologically and therapeutically active agents
GB9814238D0 (en) Biologically and therapeutically active agents
GB9914187D0 (en) Biologically active materials
GB0019100D0 (en) Biologically and therapeutically active agents
GB0019101D0 (en) Biologically and therapeutically active agents
GB9711697D0 (en) Biologically and therapeutically active agents